Yukopf Capsule (Theobromine)

Adult dose

Adults: Administer 1 capsule per dose orally twice daily.

This medication should not be used in patients with hypersensitivity to xanthine drugs, or those who have experienced severe side effects from xanthine drugs in the past. Patients with peptic ulcers, convulsive symptoms, acute infectious lung diseases, tuberculosis, liver disorders, acute nephritis, congestive heart failure, alcohol dependence, hypoxemia, hypertension, hypertrophic cardiomyopathy, tachyarrhythmia, myocardial infarction, and hypotension should use this medication with caution. Taking this medication may cause symptoms such as headache, dizziness, nausea, and rarely allergic reactions like itching or rash. Additionally, symptoms of the central nervous system such as drowsiness, muscle pain, and insomnia as well as gastrointestinal symptoms like abdominal distension, loss of appetite, constipation, diarrhea, dry mouth, heartburn, and vomiting may also occur. Liver function abnormalities may cause increases in ALT and AST levels, and there is a possibility of elevated uric acid levels in the blood. Symptoms such as swelling, facial swelling, palpitations, pharyngitis, fever, and sweating have also been reported. Particularly in the elderly, there may be a higher incidence of side effects, so caution is advised. This medication may not be well excreted in patients with liver or kidney dysfunction, heart failure, elderly patients, or those with viral infections, so caution should be exercised when taking it. Taking this medication with caffeine-containing drinks or other xanthine drugs may cause interactions, so caution is advised, and care should also be taken when used in combination with central nervous system stimulants or sympathomimetics. Moreover, it may affect the concentration of this medication in the body when used with several other drugs, so consultation with a physician or pharmacist is necessary before use. Women who are pregnant or may become pregnant should use this medication only when necessary, and nursing mothers should also consider the risks to the baby and therapeutic effects before use. Safety and effectiveness have not been fully confirmed for children or adolescents under 18 years old, or elderly patients over 70 years of age, so caution should be exercised in these populations. In cases of overdose, symptoms such as nausea, vomiting, headache, insomnia, anxiety, seizures, and arrhythmias may occur, so immediate medical treatment should be sought, and gastric lavage or drug detoxification may be performed if necessary. This medication should be stored out of the reach of children, and transferring it to another container is not recommended as it may be harmful to the quality.

• Headache
• dizziness
• nausea
• itching
• rash
• drowsiness
• muscle pain
• insomnia
• abdominal bloating
• loss of appetite

This medication should be stored in a tightly sealed container to prevent contact with air or moisture. It is best kept at room temperature between 1°C and 30°C.

Appearance

A hard capsule with a dark yellow upper part and a white lower part filled with white powder

Package unit

30 capsules/bottle, 300 capsules/bottle